Alamos Gold Inc. - AGI STOCK NEWS

Alamos Gold reported record annual gold production of 567,000 ounces in 2024, a 7% increase from 2023, meeting their revised guidance. The company projects a 24% production growth by 2027, with costs expected to decrease approximately 10% to between $1,125 and $1,225 per ounce.

The company announced construction of the Lynn Lake project in Manitoba, expected to start production in early 2028, adding approximately 176,000 ounces annually. Fourth quarter 2024 production was 140,200 ounces, with total 2024 revenue reaching a record $1.3 billion from sales of 560,234 ounces at an average price of $2,379 per ounce.

Alamos ended 2024 with approximately $325 million in cash, up from $225 million at the end of 2023. The company maintains a net cash position with $250 million drawn on its credit facility.

Alamos Gold reported new drilling results from its Island Gold Mine, showing high-grade gold mineralization extensions across the deposit. The exploration program, with a $19 million budget in 2024, completed 50,416m of underground exploration drilling and 9,849m of surface drilling.

Notable high-grade intersections include 67.68 g/t Au over 3.61m in Island West and 55.50 g/t Au over 3.87m in Island East. Delineation drilling revealed significant zones including 31.42 g/t Au over 17.87m.

The company expects these results to drive another year of growth in Mineral Reserves and Resources, marking the ninth consecutive year of expansion. The deposit remains open laterally and down-plunge, with new high-grade discoveries in hanging wall and footwall zones suggesting further growth potential near existing infrastructure.

Alamos Gold (TSX:AGI; NYSE:AGI) has appointed J. Robert S. Prichard as Chair of the Board of Directors, effective January 8, 2025. Prichard succeeds Paul Murphy, who passed away in December 2024 after serving on the Board for over 14 years, including nine years as Chairman.

Prichard, who joined the Alamos Board in May 2019, brings significant experience as the non-executive Chairman of Torys LLP and former Chair of BMO Financial Group. He currently serves as Director of Onex , Wittington Investments , Chair of VIA HFR, and Vice Chair of the Rideau Hall Foundation. His background includes leadership roles in academia as President Emeritus of the University of Toronto and corporate positions as President and CEO of Torstar and Metrolinx.

Alamos Gold (TSX:AGI; NYSE:AGI) has announced the renewal of its Normal Course Issuer Bid program, allowing the company to repurchase up to 18,605,661 Class A Common Shares, representing 5% of its public float and 4.4% of total issued shares as of December 13, 2024. The buyback program will run from December 24, 2024, to December 23, 2025, with purchases to be made through the TSX, alternative Canadian trading systems, and NYSE.

The daily purchase limit on TSX is set at 191,171 shares. The company believes its shares are trading at a discount to their underlying value, making the buyback advantageous for shareholders. Under its previous program ending December 23, 2024, which allowed for up to 34,485,405 shares, no purchases were made.

Alamos Gold (TSX:AGI; NYSE:AGI) has announced the passing of Chairman Paul J. Murphy, who served on the Board for over 14 years, including nine years as Chairman. Murphy joined as a Director in 2010 and became Chair in 2015, overseeing significant company growth. Prior to Alamos, he was a Partner at PricewaterhouseCoopers from 1981 to 2010, serving as National Mining Leader from 2004 to 2010. His career focused primarily on the resource sector, working with major international oil and gas and mining companies.

Alamos Gold has declared a quarterly dividend of US$0.025 per common share, payable on December 19, 2024, to shareholders of record as of December 5, 2024. The company has maintained a 15-year consecutive dividend payment history, returning $41 million to shareholders in 2024. Additionally, Alamos offers a Dividend Reinvestment Plan (DRIP) allowing shareholders to receive common shares instead of cash dividends at a 2% discount to market price, with enrollment required by 4:00 pm ET, five business days before the record date.

Alamos Gold (AGI) reported record Q3 2024 results with production of 152,000 ounces of gold, a 9% increase from Q2. The company generated record quarterly revenues of $360.9 million, up 41% year-over-year, driven by strong gold prices averaging $2,458 per ounce. The acquisition of Magino mine was completed on July 12, 2024, leading to increased 2024 production guidance of 550,000-590,000 ounces.

The company reported strong free cash flow of $87.5 million and adjusted net earnings of $78.1 million ($0.19 per share). Total cash costs were $984 per ounce with all-in sustaining costs of $1,425 per ounce. Cash and cash equivalents stood at $291.6 million as of September 30, 2024.

Alamos Gold Inc. (TSX:AGI; NYSE:AGI) has announced the release date for its third quarter 2024 financial results. The company will publish the results after market close on Wednesday, November 6, 2024. A conference call with senior management is scheduled for Thursday, November 7, 2024 at 11:00 am ET to discuss the results.

Participants can join the conference call via webcast or through dial-in numbers provided for Toronto and International, as well as toll-free options for Canada and the United States. A playback of the call will be available until December 7, 2024, and the webcast will be archived on the company's website.

Alamos Gold Inc. (TSX:AGI; NYSE:AGI) has announced a $2 million contribution over ten years to The Princess Margaret Cancer Foundation to create the new Alamos Gold Chair in Gastrointestinal Surgical Oncology. Dr. Catherine O'Brien was named the inaugural Chair, effective August 1, 2024, for an initial five-year term. The funding aims to support advanced research in gastrointestinal cancers, focusing on improving early detection, developing more effective treatments, and ultimately saving lives.

Gastrointestinal cancers, affecting the stomach, liver, pancreas, colorectal region, esophagus, and small intestine, pose a significant health challenge in Canada. Over 30,000 Canadians are diagnosed with these cancers annually, with colorectal cancer accounting for approximately 26,000 cases. The research initiatives supported by this funding will include clinical trials, biomarker discovery, and studies into genetic and environmental factors contributing to gastrointestinal cancers.